Scientists have found the primary psychoactive component of marijuana in 63% of breast milk samples for up to six days after the mother’s last reported use.
A large-scale genetic study found that some of the same genes associated with the use of cannabis are also associated with certain personality types and psychiatric conditions.
EHP-101 has shown promise for the modulation of relevant multiple sclerosis targets, having PPARγ and CB2-mediated anti-inflammatory activity, and the potential to enhance remyelination.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
The project will investigate the pain relief properties of CBD oil by exploring its mechanism of action in pain and associated depression and anxiety.
A team at Medicinal Genomics have successfully sequenced the cannabis genome at 640kb N50, representing a 28% improvement on the Human Genome Project standard.
The media is claiming that long-term cannabis use could result in damage to the human brain based on findings from a research study that used neither cannabis or humans.
This is the first time scientists have reported a biological mechanism to explain why some marijuana users have reported beneficial effects from cannabis on intestine inflammation conditions such as ulcerative colitis and Crohn's disease.